Scientific Sessions 2025  /  Cardiovascular Precision Therapy is at the Bedside  /  CRISPR, RNA, and the Fight Against Cardiac Amyloidosis
Logo

American Heart Association

  46
  0

Final ID:

CRISPR, RNA, and the Fight Against Cardiac Amyloidosis

  • Alexander, Kevin  ( Stanford University , Palo Alto , California , United States )
  • Arora, Pankaj  ( UNIVERSITY OF ALABAMA AT BIRMINGHAM , Birmingham , Alabama , United States )
    • Author Disclosures:
    Kevin Alexander: DO have relevant financial relationships ; Consultant:Arbor Biotechnologies:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Consultant:Alexion:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Bridgebio:Active (exists now) ; Consultant:Alnylam:Active (exists now) | Pankaj Arora: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiovascular Precision Therapy is at the Bedside

Monday, 11/10/2025 , 03:15PM - 04:30PM

Main Event

More abstracts on this topic:
Navigating the Gene Therapy Frontier: Risks, Rewards, and Patient Safety

Mcnally Elizabeth, Rossano Joseph

Gene Therapy for Heart Failure: From Bench to Bedside

Hajjar Roger, Rossano Joseph

More abstracts from these authors:
Serum Biomarkers of Cardiac Stress and Heart Failure Prevention: Ready for Prime Time?

Januzzi James, Arora Pankaj

Targeting Cardiac Amyloidosis with siRNA: A New Era in Therapeutic Intervention

Arora Pankaj

You have to be authorized to contact abstract author. Please, Login
Not Available